{Reference Type}: Letter
{Title}: Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China.
{Author}: Fu ZC;Cheng XG;Zhang GW;Shi RG;Zhang LJ;Sun HT;Huang JX;
{Journal}: Int J Rheum Dis
{Volume}: 27
{Issue}: 5
{Year}: 2024 May
{Factor}: 2.558
{DOI}: 10.1111/1756-185X.15190